期刊档案 · INTEGRATIVE & COMPLEMENTARY MEDICINE
Journal of Ayurveda and Integrative Medicine
ISSN 0975-9476 · eISSN 0976-2809 · Elsevier · India
Journal of Ayurveda and Integrative Medicine 中科院 医学 4区（2025 年升级版），影响因子 2.1（官网公布），钻石开放获取（无 APC），免版面费，近 24 个月 98 篇文章投稿到接收中位 202 天，2025 年发文 157 篇，ESCI、Scopus 收录。
研究范围
研究范围与定位
Journal of Ayurveda and Integrative Medicine 由 Elsevier 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Phytochemicals and Medicinal Plants、Complementary and Alternative Medicine Studies、Traditional Chinese Medicine Studies 等主题的论文，这 3 个主题约占 41.9%，主导子领域为 Complementary and alternative medicine。（根据 OpenAlex 主题统计与中科院分区数据生成）
The Journal of Ayurveda and Integrative Medicine (J-AIM) is internationally circulated open access official publication of World Ayurveda Foundation and Trans-Disciplinary University, Bengaluru. As a trans-disciplinary platform for integrative health sciences, J-AIM aims to explore the relationships between Ayurveda, traditional medicine, biomedicine and other contemporary health sciences, encouraging meaningful collaboration to promote effective, safe and affordable global health.J-AIM encourages collaboration and communications between professional, academic and scientific communities. It publishes critical aspects of intellectual and scientific communication focused on Ayurveda, traditional medicine and biomedicineto facilitate integrative approaches to global healthcare.Articles explaining and exploring principles of Ayurveda and traditional medicine; theoretical, experimental, and clinical research; evidence based clinical practice promoting trans-disciplinary research culture and mainstreaming traditional medicine using advances in biomedicine, basic sciences and technology as well as articles envisioning future scope, research areas and priorities will be considered.J-AIM also encourages articles investigating biological effects of traditional medicines, pharmacological and physiological interventions. It welcomes research that endeavors to design and development of new protocols, reporting standards, processes, methods, pharmaceutics, quality control, instruments, clinical practice and translation into healthcare systems.J-AIM Editorial Board and reviewers comprise expert academicians, researchers and clinicians who help for capacity and competency building in scientific writing. Effective and user friendly manuscript processing system of the journal facilitate review process for timely decisions and publications. The journal is a member of reputed international bodies like World Association of Medical Editors, Indian Association of Medical Journal Editors, and Committee of Publication Ethics (COPE). J-AIM is indexed in PubMed and Scopus among many others.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：INTEGRATIVE & COMPLEMENTARY MEDICINE
主编 Bhushan Patwardhan出版商官网
编委会国家分布：中国大陆 1 位（约 1%）；主要国家 印度 40、美国 14、澳大利亚 5、英国 2、瑞士 2（共 76 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Phytochemicals and Medicinal PlantsMedicine22.8%
- Complementary and Alternative Medicine StudiesMedicine12.1%
- Traditional Chinese Medicine StudiesMedicine7%
- Ethnobotanical and Medicinal Plants StudiesAgricultural and Biological Sciences4.8%
- Mindfulness and Compassion InterventionsPsychology4.7%
- Medicinal Plants and NeuroprotectionMedicine4.3%
- Natural Antidiabetic Agents StudiesMedicine3.9%
- Acupuncture Treatment Research StudiesMedicine3.7%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 全科医学与补充医学INTEGRATIVE & COMPLEMENTARY MEDICINE | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 全科医学与补充医学INTEGRATIVE & COMPLEMENTARY MEDICINE | 4 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
PubMed出版商官网
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布）
- 2.1出版商官网 ·
- CiteScore 2026-06
- 4.2LetPub ·
- CiteScore（出版商公布）
- 4.2出版商官网 ·
- SJR 2026-06
- 0.38LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 60OpenAlex ·
- i10-index
- 575OpenAlex ·
- 两年平均被引
- 2.22OpenAlex ·
- 自引率
- 14.3%LetPub ·
- Gold OA 文章占比
- 100%LetPub ·
发文规模
- 年文章数
- 143LetPub ·
逐年发文量 OpenAlex 统计 · 累计 1,581 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 88 | 88 | 17 |
| 2025 | 157 | 157 | 221 |
| 2024 | 154 | 154 | 646 |
| 2023 | 116 | 116 | 924 |
| 2022 | 116 | 116 | 1,112 |
| 2021 | 154 | 154 | 1,945 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
202 天投稿到接收中位数 · P25–P75 136 天 – 293 天
- 接收到上线
- 中位数 97 天（98 篇）
- 投稿到上线
- 中位数 307 天
- 样本
- 98 篇有投稿与接收日期的文章（窗口内共 272 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 30 WeeksLetPub ·
- 投稿到发表（期刊自报）
- 约 58 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
钻石开放获取（无 APC）DOAJ
所有文章开放获取，且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY、CC BY-NC-ND | |
| OpenAlex | USD 1,800 / EUR 1,680 / GBP 1,440 / JPY 223,250 | — | — | |
| LetPub | USD 1,800 | 有 | — | |
| 出版商官网 | USD 2,070 | — | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
征稿中的专刊1 个，按截稿日期
出版商官网投稿准备要点3 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- ≥ 1 个
- 正文篇幅
- ≤ 5,000 词
接收的文章类型24 种，含篇幅限制
- book reviewContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- case reportContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…正文 ≤ 1,500 词 · 摘要 ≤ 200 词 · 参考文献 ≤ 20
- case report (case series)Case Report (Case Series)未说明篇幅
- commentaryContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- conference reportContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…正文 ≤ 1,200 词
- correspondenceContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- correspondence (letters)Correspondence (Letters)未说明篇幅
- discussion (discussion kernel, commentary)Discussion (Discussion Kernel, Commentary)未说明篇幅
- editorialContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- general articleFull Length Article (Original Research Article (Experimental), Original Research Article (Clinical), General Article, Pedagogy)未说明篇幅
- letterContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- opinionContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- opinion paper (thought leadership article)Opinion Paper (Thought Leadership Article): Please restrict non-structured abstract to 250 words and manuscript to about 2000 words (excluding about 20 referenc…未说明篇幅
- original research articleContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- original research article (clinical)Original Research Article (Clinical): This section reports clinical research, within the scope of J-AIM. Clinical studies may include clinical trials, cross sec…未说明篇幅
- original research article (experimental)Original Research Article (Experimental): Please restrict the structured abstract to 250 words (background, objectives, material and methods, results, conclusio…未说明篇幅
- pedagogyFull Length Article (Original Research Article (Experimental), Original Research Article (Clinical), General Article, Pedagogy)未说明篇幅
- practice guidelinesPractice Guidelines未说明篇幅
- product reviewProduct Review未说明篇幅
- research articleContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- reviewContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- review articleContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- short communicationContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…未说明篇幅
- short reviewContributions falling into the following categories will be considered for publication:Editorial, Opinion Paper (Thought Leadership Article), Full Length Articl…正文 ≤ 2,000 词
官网政策摘录AI 使用、作者资格、利益冲突、出版伦理、许可与版权、开放获取、同行评审、预印本
- AI 使用 Declaration of generative AI use
作者必须在提交论文时声明在稿件准备过程中使用生成式AI工具的情况。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Authorship
遵守上述作者身份要求即符合国际医学期刊编辑委员会（ICMJE）2024年1月更新版的作者身份标准。 模型中文摘要
By adhering to the authorship requirements stated above, authors meet the International Committee of Medical Journal Editors (ICMJE) criteria [updated version January 2024] on authorship.
原文 ↗出版商官网 ·- 利益冲突 Declaration of competing interests
所有作者必须披露可能不当影响或偏倚其工作的与他人或组织的财务和个人关系，并始终完成声明工具。 模型中文摘要
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
原文 ↗出版商官网 ·- 出版伦理
作者必须遵守Elsevier出版伦理政策中规定的伦理准则。 模型中文摘要
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
原文 ↗出版商官网 ·- 许可与版权 Copyright
在机构外转售或分发以及所有其他衍生作品（包括汇编和翻译）需要学会许可；引用其他受版权保护的作品片段时，作者必须获得版权所有者的书面许可并在文章中注明出处。 模型中文摘要
Permission of the Society is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.
原文 ↗出版商官网 ·- 开放获取 Open access
开放获取选项请参阅开放获取信息页面。 模型中文摘要
We refer you to our open access information page to learn about open access options for this journal.
原文 ↗出版商官网 ·- 同行评审 Peer review
本刊采用双盲同行评审，编辑初步评估后通常至少送两名审稿人独立评审，录用与否由编辑决定，且编辑不参与处理其本人撰写、由亲属或同事撰写或涉及其利益的产品或服务的论文。 模型中文摘要
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
原文 ↗出版商官网 ·- 预印本 Preprints
作者可按Elsevier文章共享政策共享预印本，共享预印本（如在预印本服务器上）不计作先前发表。 模型中文摘要
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Elsevier
- 出版国家或地区
- India
- 出版语言
- English
- ISSN
- 0975-9476
- 电子版 ISSN
- 0976-2809
- 学会 / 主办单位
- World Ayurveda Foundation and Trans-Disciplinary University
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗出版商官网
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 Journal of Ayurveda and Integrative Medicine 的常见问题
Journal of Ayurveda and Integrative Medicine 是中科院几区期刊？
2025 年升级版分区表中，Journal of Ayurveda and Integrative Medicine 为医学 4区，小类 全科医学与补充医学 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Journal of Ayurveda and Integrative Medicine 的影响因子是多少？
期刊官网公布的影响因子为 2.1，属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 4.2，h-index 为 60。
Journal of Ayurveda and Integrative Medicine 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）98 篇已发表文章登记的日期，投稿到接收的中位数为 202 天（四分位 136–293 天）；投稿社区反馈的平均审稿速度为约 30 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Journal of Ayurveda and Integrative Medicine 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：≥ 1 个；正文篇幅：≤ 5,000 词。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Journal of Ayurveda and Integrative Medicine 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 76 位编委中，中国大陆 1 位（约 1%）；人数最多的国家是 印度（40 位）、美国（14 位）、澳大利亚（5 位）。统计按编委会页面列出的机构国家计，仅供参考。
Journal of Ayurveda and Integrative Medicine 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Journal of Ayurveda and Integrative Medicine 被 ESCI、Scopus、DOAJ 收录。期刊官网自述还被 PubMed 收录，该清单未与各数据库逐一核对。
Journal of Ayurveda and Integrative Medicine 是开放获取期刊吗？版面费多少？
Journal of Ayurveda and Integrative Medicine 为钻石开放获取（无 APC）。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网、DOAJ；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。